- Home
- ATER vs MRKR Comparison
ATER vs MRKR Comparison
Compare ATER & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- MRKR
- Stock Information
- Founded
- ATER 2014
- MRKR N/A
- Country
- ATER United States
- MRKR United States
- Employees
- ATER N/A
- MRKR N/A
- Industry
- ATER Home Furnishings
- MRKR Biotechnology: Pharmaceutical Preparations
- Sector
- ATER Consumer Discretionary
- MRKR Health Care
- Exchange
- ATER Nasdaq
- MRKR Nasdaq
- Market Cap
- ATER 15.5M
- MRKR 17.7M
- IPO Year
- ATER N/A
- MRKR N/A
- Fundamental
- Price
- ATER $1.26
- MRKR $1.19
- Analyst Decision
- ATER
- MRKR Strong Buy
- Analyst Count
- ATER 0
- MRKR 3
- Target Price
- ATER N/A
- MRKR $13.17
- AVG Volume (30 Days)
- ATER 66.5K
- MRKR 3.5M
- Earning Date
- ATER 08-13-2025
- MRKR 08-18-2025
- Dividend Yield
- ATER N/A
- MRKR N/A
- EPS Growth
- ATER N/A
- MRKR N/A
- EPS
- ATER N/A
- MRKR N/A
- Revenue
- ATER $94,191,000.00
- MRKR $5,696,123.00
- Revenue This Year
- ATER N/A
- MRKR N/A
- Revenue Next Year
- ATER $7.48
- MRKR $7.16
- P/E Ratio
- ATER N/A
- MRKR N/A
- Revenue Growth
- ATER N/A
- MRKR 71.53
- 52 Week Low
- ATER $1.15
- MRKR $0.95
- 52 Week High
- ATER $3.84
- MRKR $5.95
- Technical
- Relative Strength Index (RSI)
- ATER 43.43
- MRKR 35.51
- Support Level
- ATER $1.16
- MRKR $1.15
- Resistance Level
- ATER $1.21
- MRKR $1.61
- Average True Range (ATR)
- ATER 0.05
- MRKR 0.12
- MACD
- ATER 0.00
- MRKR -0.04
- Stochastic Oscillator
- ATER 44.00
- MRKR 16.36
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.